金达威:巴西甜蛋白获美国FDA GRN 001305无异议函

智通财经
Oct 08
【金达威:巴西甜蛋白获美国FDA GRN 001305无异议函】金达威公告,全资子公司内蒙古金达威药业有限公司巴西甜蛋白产品已完成FDA GRAS通告评估,并收到美国食品药品监督管理局出具的GRAS Notice No.GRN 001305无异议回复函。FDA对该产品申报用途下的GRAS结论出具无异议意见。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10